2563.HK · BIOSTAR PHARM-B
Hong Kong · RS rating 64 · As of 2026-10-14
| Price | 4.00 HKD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 33 / 75 / 19 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 29 / 34 / 9 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +52.7% |
| Market cap (USD) | $213.5M |